The Value of Annual PET/CT as a Screening Tool for Myeloma Patients

In last week’s blog, How to Be Safer as You Live Longer,” I cited the value of annual PET/CT as a screening tool to monitor low-level myeloma, detect hidden infection or an early second cancer. This prompted one reader to comment that “Medicare and supplemental insurance companies will not yet cover the cost of the procedure as a screening tool” and to ask for some “practical help” to obtain coverage.

Diagnosing Myeloma Early: New IMWG Guidelines

For some time, members of theInternational Myeloma Working Group (IMWG), the IMF's research division, have been trying to identify and describe a group of patients without